Literature DB >> 3932214

Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

M A Luzar, M J Thomassen, T C Montie.   

Abstract

Selected physiological parameters of 31 classic and rough Pseudomonas aeruginosa strains from respiratory tract cultures of patients with cystic fibrosis were examined. An association of a patient's clinical condition (good or poor) with strain physiology was made. Rough strains from patients in poor clinical condition demonstrated severe alterations in motility when compared with M-2, a highly motile and chemotactic burn strain. Of the 10 rough strains from patients in poor clinical condition, 70% lacked flagella, as determined by electron microscopy. The remaining few flagellated strains from this group exhibited weak motility both in soft agar and by the capillary assay. Their chemotactic response to three amino acids, when compared with that of strain M-2, was reduced approximately 30 to 90%. Classic strains from patients in poor clinical condition were less chemotactic than those from patients in good clinical condition. A majority of classic and rough strains from patients in good clinical condition were comparable to M-2 in both chemotaxis and motility. Changes in other physiological characteristics indicated by reduced growth rates, or auxotrophy, were seldom observed in the cystic fibrosis strains studied. The data suggest that host-selective pressures, associated primarily with patients with cystic fibrosis that are in poor clinical condition, result in the loss of factors related to invasiveness such as motility and chemotaxis. We propose that these results may reflect that there is a more general alteration in the cell envelope of cystic fibrosis strains.

Entities:  

Mesh:

Year:  1985        PMID: 3932214      PMCID: PMC261995          DOI: 10.1128/iai.50.2.577-582.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA.

Authors:  A H WAHBA; J H DARRELL
Journal:  J Gen Microbiol       Date:  1965-03

2.  Serum levels of gentamicin and tobramycin after slow intravenous bolus injection.

Authors:  B C Stratford; S Dixson; A J Cobcroft
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

3.  Bacterial infection in cystic fibrosis.

Authors:  J R May; N C Herrick; D Thompson
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

4.  A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli.

Authors:  J Adler
Journal:  J Gen Microbiol       Date:  1973-01

5.  A report on sixty-five patients over 17 years of age.

Authors:  H Shwachman; L L Kulczycki; K T Khaw
Journal:  Pediatrics       Date:  1965-11       Impact factor: 7.124

6.  Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.

Authors:  N Hoiby
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-08

7.  Serological properties of Pseudomonas aeruginosa. II. Type-specific thermolabile (flagellar) antigens.

Authors:  B Lányi
Journal:  Acta Microbiol Acad Sci Hung       Date:  1970

8.  Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production.

Authors:  J R Govan
Journal:  J Med Microbiol       Date:  1975-11       Impact factor: 2.472

9.  Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families.

Authors:  L R Laraya-Cuasay; K R Cundy; N N Huang
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

10.  Alterations in the outer membrane of the cell envelope of heptose-deficient mutants of Escherichia coli.

Authors:  J Koplow; H Goldfine
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

View more
  66 in total

1.  Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU).

Authors:  E S Garrett; D Perlegas; D J Wozniak
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression.

Authors:  Eyal Amiel; Rustin R Lovewell; George A O'Toole; Deborah A Hogan; Brent Berwin
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

3.  Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.

Authors:  Ashley E Warren; Carla M Boulianne-Larsen; Christine B Chandler; Kami Chiotti; Evgueny Kroll; Scott R Miller; Francois Taddei; Isabelle Sermet-Gaudelus; Agnes Ferroni; Kathleen McInnerney; Michael J Franklin; Frank Rosenzweig
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

4.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  The Interaction between Respiratory Pathogens and Mucus.

Authors:  Mark Zanin; Pradyumna Baviskar; Robert Webster; Richard Webby
Journal:  Cell Host Microbe       Date:  2016-02-10       Impact factor: 21.023

6.  Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections.

Authors:  Dao Nguyen; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

7.  Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.

Authors:  T R Anderson; T C Montie; M D Murphy; V P McCarthy
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

Authors:  Teresa A Urban; Adam Griffith; Anastasia M Torok; Mark E Smolkin; Jane L Burns; Joanna B Goldberg
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 9.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

10.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.